After an initial loading regimen of 1mg three times weekly for two weeks, maintenance therapy is typically 1mg every three months for life in conditions like pernicious anaemia, or every two months if neurological involvement was present
On the other hand, there is virtually nothing to worry about with topical AHK-Cu application
There is simply too much of a risk as a consumer to gamble with your health by ingesting a research compound without a regulated lab behind it. The regulatory picture is shifting fast
Stable gastric pentadecapeptide BPC 157: novel mediator of Roberts cytoprotection and adaptive cytoprotection. Current Pharmaceutical Design, 20(7), 11261135
A peptide stack is a combination of two or more peptides used together to produce synergistic results
A PCAC review is scheduled for July 2026, and multiple compounding groups have petitioned for Category 1 reclassification, citing the 2025 IV safety pilot (PMID 40131143) and growing clinical experience